The bacterium Clostridioides difficile is named “difficult” for a reason. Originally it was hard to grow in the lab, and now ...

An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.

Have close contact with someone who has been diagnosed with C. diff. Hospitals try to prevent C diff. among patients in several ways. They impose scrupulous hand-washing requirements among staff ...

Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

Study finds underutilization of fidaxomicin, a recommended treatment for C. diff infection, despite increased use in hospitals.

The bacterium Clostridioides difficile is one of the most common infections picked up in hospitals, and, even once it’s cleared from the body, patients have a 1 in 6 chance of catching it again ...

Pfizer's vaccine for Clostridium difficile (C. diff) looks like it may join a growing list of candidates that have been shelved or delayed, after the shot failed to meet its primary objective in a ...

The superbug Clostridioides difficile, or C. diff, can cause dangerous gut infections. There are limited options for treating ...

C. diff causes nearly 30,000 deaths each year in the US, says Ferring, and recurrent infections with the bacterium make up 10%-15% of all hospital-treated infections.

Research by the University of Plymouth showed spores of Clostridium difficile, commonly known as C. diff, are completely unaffected despite being treated with high concentrations of bleach used in ...

Purpose The pharmacology, clinical efficacy, safety, dosage and administration, and place in therapy of fidaxomicin for the treatment of Clostridium difficile infection (CDI) are reviewed.

H. pylori infections occur across the world due to exposure to saliva or stool in contaminated water or food. Learn how the ...